MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Globus Medical DPO Ratio 2011-2025 | GMED
Annual DPO Ratio Globus Medical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.2 | 30.9 | 40.2 | 30.6 | 35.9 | 49.9 | 59.3 | 60.7 | 47.3 | 43.9 | 70 | 46.3 | 60.9 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70 | 23.2 | 46.1 |
Quarterly DPO Ratio Globus Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.5 | 29.4 | 30.5 | 21 | 20.6 | 26 | 40.7 | 43.9 | 25.7 | - | 22.3 | 17.4 | 37 | - | 32.7 | 31.2 | 33.7 | - | 29.1 | 32.8 | 40 | - | 49.5 | 51.5 | 55.5 | - | 62.4 | 62.8 | 61.2 | - | 62.1 | 61.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 62.8 | 17.4 | 38.9 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B |  USA |
 |
Abiomed
ABMD
|
76.2 | - | - | $ 17.2 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Apyx Medical Corporation
APYX
|
52.8 | $ 3.78 | -2.01 % | $ 131 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
41 | $ 306.14 | -0.65 % | $ 8.64 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
InMode Ltd.
INMD
|
65.1 | $ 14.33 | -1.24 % | $ 1.14 B |  Israel |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 0.98 | 5.89 % | $ 15.8 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 45.61 | 1.05 % | $ 6.8 K | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
82.8 | $ 128.15 | 2.14 % | $ 223 B | USA |
 |
Boston Scientific Corporation
BSX
|
66 | $ 91.93 | -0.7 % | $ 135 B | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
71.8 | $ 63.0 | 0.4 % | $ 3.42 B |  Britain |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.27 | 13.54 % | $ 122 M |  France |
 |
LENSAR
LNSR
|
66 | $ 11.73 | 1.91 % | $ 135 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
PAVmed
PAVM
|
128 | $ 0.31 | -4.73 % | $ 2.24 M | USA |
|
Cognyte Software Ltd.
CGNT
|
81.1 | $ 9.6 | -2.64 % | $ 689 M | Israel |
 |
IRadimed Corporation
IRMD
|
40.6 | $ 96.49 | 0.26 % | $ 1.22 B | USA |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
Quanterix Corporation
QTRX
|
31.3 | $ 7.48 | -1.06 % | $ 281 M | USA |
 |
Align Technology
ALGN
|
33.7 | $ 163.48 | -1.18 % | $ 12.2 B | USA |
 |
Accuray Incorporated
ARAY
|
49.2 | $ 1.05 | -0.94 % | $ 108 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
25.8 | $ 12.59 | -0.94 % | $ 340 M | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 14.9 | 1.02 % | $ 97.7 M | USA |
 |
AxoGen
AXGN
|
79.6 | $ 29.87 | -1.71 % | $ 1.32 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
CONMED Corporation
CNMD
|
60.6 | $ 40.13 | -1.71 % | $ 1.24 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
70.1 | $ 17.69 | 0.51 % | $ 408 M | USA |
 |
Sensus Healthcare
SRTS
|
14.7 | $ 3.69 | -3.79 % | $ 60.2 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 13.55 | 0.93 % | $ 1.04 B | USA |